Slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,720 NZD | -2,51% |
|
-4,56% | -6,21% |
Voorlopige winst- en verliesrekening: AFT Pharmaceuticals Limited
Fiscaal tijdperk: Maart | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Omzet 1 | 105,6 | 113,1 | 130,3 | 156,6 | 195,4 | 214,8 | 255,8 | 289,9 |
Variatie | - | 7,11% | 15,22% | 20,2% | 24,75% | 9,94% | 19,08% | 13,31% |
EBITDA 1 | 12,52 | 11,81 | 21,43 | 21,39 | 26,25 | 19,83 | 28,82 | 36,65 |
Variatie | - | -5,67% | 81,45% | -0,19% | 22,69% | -24,44% | 45,33% | 27,16% |
Bedrijfsresultaat (EBIT) 1 | 11,42 | 10,71 | 20,39 | 19,67 | 24,24 | 17,3 | 26,11 | 33,72 |
Variatie | - | -6,25% | 90,41% | -3,53% | 23,21% | -28,6% | 50,89% | 29,15% |
Betaalde rente 1 | -8,329 | -2,821 | -1,704 | -3,87 | -2,216 | -2,5 | -2,4 | -2,2 |
Resultaat voor belastingen (EBT) 1 | 12,88 | 7,887 | 18,68 | 15,8 | 22,02 | 14,4 | 22,2 | 26,1 |
Variatie | - | -38,75% | 136,91% | -15,45% | 39,37% | -34,6% | 54,17% | 17,57% |
Nettowinst (verlies) 1 | 12,7 | 7,8 | 19,85 | 10,65 | 15,61 | 11,93 | 18,4 | 23,03 |
Variatie | - | -38,58% | 154,46% | -46,32% | 46,51% | -23,57% | 54,25% | 25,17% |
Datum van publicatie | 19-05-20 | 23-05-21 | 22-05-22 | 22-05-23 | 22-05-24 | - | - | - |
Balansprognose: AFT Pharmaceuticals Limited
Fiscaal tijdperk: Maart | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Nettoschuld 1 | 41,1 | 35,2 | 29,3 | 29,9 | 16,2 | 17,4 | 17,6 | 15,1 |
Variatie | - | -14,36% | -16,76% | 2,05% | -45,82% | 7,41% | 1,15% | -14,2% |
Datum van publicatie | 19-05-20 | 23-05-21 | 22-05-22 | 22-05-23 | 22-05-24 | - | - | - |
Verwachte kasstroom: AFT Pharmaceuticals Limited
Fiscaal tijdperk: Maart | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 6,562 | 6,231 | 5,585 | 9,177 | 9,527 | 7,66 | 8,102 | 8,54 |
Variatie | - | -5,04% | -10,37% | 64,32% | 3,81% | -19,59% | 5,77% | 5,4% |
Vrije kasstroom (FCF) 1 | - | -5,481 | 8,567 | 2,452 | 19,33 | - | - | - |
Variatie | - | - | -256,3% | -71,38% | 688,5% | -100% | - | - |
Datum van publicatie | 19-05-20 | 23-05-21 | 22-05-22 | 22-05-23 | 22-05-24 | - | - | - |
Verwachte financiële ratio's: AFT Pharmaceuticals Limited
Fiscaal tijdperk: Maart | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
EBITDA-marge (%) | 11,86% | 10,44% | 16,45% | 13,66% | 13,43% | 9,23% | 11,27% | 12,64% |
EBIT-marge (%) | 10,82% | 9,47% | 15,65% | 12,56% | 12,4% | 8,05% | 10,21% | 11,63% |
EBT-marge (%) | 12,19% | 6,97% | 14,34% | 10,09% | 11,27% | 6,7% | 8,68% | 9% |
Nettomarge (%) | 12,03% | 6,9% | 15,23% | 6,8% | 7,99% | 5,55% | 7,19% | 7,95% |
FCF-marge (%) | - | -4,85% | 6,57% | 1,57% | 9,89% | - | - | - |
Vrije kasstroom/nettoresultaat (%) | - | -70,27% | 43,16% | 23,01% | 123,86% | - | - | - |
Winstgevendheid | ||||||||
ROA | - | 8,1% | 17,5% | 7,74% | 9,96% | 9,78% | 13,47% | 16,68% |
ROE | 113,67% | 28,91% | 42,53% | 15,72% | 19,38% | 12,45% | 16,54% | 17,48% |
Financiële gezondheid | ||||||||
Hefboom (schuld/ebitda) | 3,28x | 2,98x | 1,37x | 1,4x | 0,62x | 0,88x | 0,61x | 0,41x |
Schuld/vrije kasstroom | - | -6,41x | 3,42x | 12,19x | 0,84x | - | - | - |
Kapitaalintensiteit | ||||||||
Kapitaaluitgaven/omzet (%) | 6,21% | 5,51% | 4,29% | 5,86% | 4,88% | 3,57% | 3,17% | 2,95% |
CAPEX / EBITDA (%) | 52,4% | 52,75% | 26,06% | 42,9% | 36,3% | 38,62% | 28,11% | 23,3% |
CAPEX / FCF (%) | - | -113,68% | 65,19% | 374,27% | 49,28% | - | - | - |
Bestanddelen per aandeel | ||||||||
Kasstroom per aandeel 1 | - | 0,00726 | 0,1352 | 0,1109 | 0,2752 | 0,1556 | 0,1907 | 0,2398 |
Variatie | - | - | 1.762,26% | -17,97% | 148,15% | -43,46% | 22,56% | 25,76% |
Dividend per aandeel 1 | - | - | - | - | 0,016 | 0,015 | 0,0224 | 0,035 |
Variatie | - | - | - | - | - | -6,25% | 49,2% | 56,39% |
Nettoactief per aandeel 1 | 0,1773 | 0,3498 | 0,542 | 0,6987 | 0,8372 | 0,3956 | 0,5324 | 0,7312 |
Variatie | - | 97,27% | 54,95% | 28,91% | 19,82% | -52,74% | 34,56% | 37,34% |
WPA 1 | 0,12 | 0,07 | 0,19 | 0,1 | 0,15 | 0,1137 | 0,1757 | 0,2195 |
Variatie | - | -41,67% | 171,43% | -47,37% | 50% | -24,21% | 54,56% | 24,94% |
Aantal aandelen (in duizend) | 97.309 | 104.584 | 104.697 | 104.866 | 104.866 | 104.866 | 104.866 | 104.866 |
Datum van publicatie | 19-05-20 | 23-05-21 | 22-05-22 | 22-05-23 | 22-05-24 | - | - | - |
2025 * | 2026 * | |
---|---|---|
P/E-ratio | 24,3x | 15,7x |
PBR-ratio | 6,98x | 5,18x |
EV/omzet | 1,43x | 1,2x |
Dividendrendement | 0,54% | 0,81% |
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
